Why Lantheus Holdings Stock Popped by Almost 12% Last Month
Source: Motley Fool
2026-03-09 17:03:29 ET
February is a frigid month in much of this country, but it wasn't all that frosty for Lantheus Holdings (NASDAQ: LNTH) . The medical device specialist unveiled its final set of financial results for 2025, ending that year on quite the high note.
In its fourth quarter, Lantheus' revenue totaled just under $407 million, up 4% from the same period in 2024. Net income not under generally accepted accounting practices (GAAP) fell at essentially the same rate to land at just under $111 million, or $1.67 per share.
Image source: Getty Images.
Lantheus Holdings Inc.
NASDAQ: LNTH
LNTH Trading
6.5% G/L:
$82.705 Last:
573,439 Volume:
$79.37 Open:
LNTH Latest News
March 06, 2026 04:01:00 pm
Lantheus Announces FDA Approval of PYLARIFY TruVu(TM) (piflufolastat F 18) Injection
LNTH Stock Data
$4,401,112,772
64,985,543
0.1%
159
N/A
Pharmaceuticals
Healthcare
US
Bedford
